Translation of Pr55gagAugments Packaging of Human Immunodeficiency Virus Type 1 RNA in aCis-Acting Manner
- 10 October 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 18 (15) , 1117-1126
- https://doi.org/10.1089/088922202320567851
Abstract
The full-length RNA of human immunodeficiency virus type 1 (HIV-1) serves both as a messenger (mRNA) to direct the translation of Pr55gag proteins and as genomic or viral particle RNA (vpRNA) to be packaged into virions. In this study, we have assessed a putative cis-acting effect of Pr55gag translation on HIV-1 RNA packaging. To pursue this subject, we have measured the relative competence of two distinct types of HIV-1 RNA for being packaged by virus particles under conditions in which only one of them is permissive for production of Pr55gag. Not surprisingly, wild-type BH10 RNA was packaged at far higher efficiency than that associated with mutant viral RNA that was deleted of RNA packaging signals and incapable of Pr55gag production. However, when production of Pr55gag was eliminated from the wild-type BH10 viral RNA by insertion of stop codons either in matrix (MA) or in capsid (CA) sequences, regardless of retention of wild-type RNA packaging signals, these Pr55gag-deficient viral RNAs were packaged at low levels similar to those observed with viral RNA species that lack RNA packaging signals and are capable of Pr55gag generation. Moreover, loss of Pr55gag production did not affect stability of the relevant viral RNA; this observation rules out the possibility that lowered packaging efficiency associated with Pr55gag-deficient HIV-1 RNA is a result of reduced RNA stability. Taken together, our data demonstrate that cis translation of Pr55gag is needed for efficient packaging of HIV-1 RNA.Keywords
This publication has 46 references indexed in Scilit:
- Human Immunodeficiency Virus Type 1 Preferentially Encapsidates Genomic RNAs That Encode Pr55Gag: Functional Linkage between Translation and RNA PackagingVirology, 2002
- The Major Human Immunodeficiency Virus Type 2 (HIV-2) Packaging Signal Is Present on All HIV-2 RNA Species: Cotranslational RNA Encapsidation and Limitation of Gag Protein Confer SpecificityJournal of Virology, 2001
- Hydrophobic Amino Acids in the Human Immunodeficiency Virus Type 1 p2 and Nucleocapsid Proteins Can Contribute to the Rescue of Deleted Viral RNA Packaging SignalsJournal of Virology, 2001
- The Human Immunodeficiency Virus Type 1gagGene Encodes an Internal Ribosome Entry SiteJournal of Virology, 2001
- 5′ Regions of HIV-1 RNAs Are Not Sufficient for Encapsidation: Implications for the HIV-1 Packaging SignalVirology, 1995
- Targeted and highly efficient gene transfer into CD4+ cells by a recombinant human immunodeficiency virus retroviral vector.Journal of Clinical Investigation, 1991
- rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.Proceedings of the National Academy of Sciences, 1989
- Stabilities of Avian Sarcoma Virus RNAs: Comparison of Subgenomic and Genomic Species with Cellular mRNAsJournal of General Virology, 1983
- Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA.Proceedings of the National Academy of Sciences, 1976
- Dependence of Moloney murine leukemia virus production on cell growthVirology, 1975